Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check3 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.3%
- Check10 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check17 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check24 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.4%
- Check31 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.0) and has removed a citation related to a study on pembrolizumab for advanced oesophageal cancer.SummaryDifference2%
- Check53 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.